Knightsbridge Asset Management »

Neurocrine Biosciences shares owned by Knightsbridge Asset Management

Quarter-by-quarter ownership of Neurocrine Biosciences (NBIX) shares owned by Knightsbridge Asset Management from 13F filings

Historical chart of Knightsbridge Asset Management investment in Neurocrine Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Neurocrine Biosciences held by Knightsbridge Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neurocrine Biosciences by Knightsbridge Asset Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $434k 3.3k 131.74
2025-12-31 $254k 1.8k 141.83

More positions owned by Knightsbridge Asset Management

Ishares Tr 0-3 Mnth Treasry (SGOV)
Wisdomtree Tr Floatng Rat Trea (USFR)
Simplify Exchange Traded Fun Mbs Etf (MTBA)
Spdr Index Shs Fds State Street Spd (SPDW)
Spdr Series Trust State Street Spd (SPYM)
Spdr Index Shs Fds State Street Spd (SPEM)
Apple (AAPL)
Alphabet Cap Stk Cl A (GOOGL)
J P Morgan Exchange Traded F Us Qualty Fctr (JQUA)
Kraneshares Trust California Carb (KCCA)
Liberty Energy Com Cl A (LBRT)
Silicon Motion Technology Sponsored Adr (SIMO)
Microsoft Corporation (MSFT)
Ishares Tr Core Div Grwth (DGRO)
NVIDIA Corporation (NVDA)

View all positions for Knightsbridge Asset Management

Top funds holding Neurocrine Biosciences

BlackRock
Vanguard Group
Dodge & Cox
AQR Capital Management
Vanguard Portfolio Management
Vanguard Capital Management
State Street Corporation
Two Sigma Investments
Renaissance Technologies
Geode Capital Management
Wellington Management Company
Bellevue Group
Bnp Paribas Investment Partners
Vestal Point Capital
Millennium Management

View all funds holding Neurocrine Biosciences